T Cell Activation in HIV 1 Reverse Transcription/Integra - Linda Ludwig

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute of Allergy and Infectious Diseases (NIAID)
Type: First Independent Research Support & Transition (FIRST) Awards (R29)
Project #: 1R29AI038114-01A2
Application #: 2075039
Study Section: AIDS and Related Research Study Section 1 (ARRA)

Project Start: 1996-07-15
Project End: 2001-06-30
Budget Start: 1996-07-15
Budget End: 1997-06-30
Support Year: 1
Fiscal Year: 1996
Total Cost
Indirect Cost

Institution

Name: State University of New York at Buffalo
Department: Internal Medicine/Medicine
Type: Schools of Medicine
DUNS #: 038633251

City: Buffalo
State: NY
Country: United States
Zip Code: 14260

Related projects


NIH 2000 R29 AI	T Cell Activation in HIV 1 Reverse Transcription/Integra Ludwig, Linda B. / State University of New York at Buffalo	$57,716
NIH 1999 R29 AI	T Cell Activation in HIV 1 Reverse Transcription/Integra Ludwig, Linda B. / State University of New York at Buffalo
NIH 1998 R29 AI	T Cell Activation in HIV 1 Reverse Transcription/Integra Ludwig, Linda B. / State University of New York at Buffalo
NIH 1997 R29 AI	T Cell Activation in HIV 1 Reverse Transcription/Integra Ludwig, Linda B. / State University of New York at Buffalo
NIH 1996 R29 AI	T Cell Activation in HIV 1 Reverse Transcription/Integra Ludwig, Linda B. / State University of New York at Buffalo

Publications

Ludwig, Linda B; Ambrus Jr, Julian L; Krawczyk, Kristie A et al. (2006) Human Immunodeficiency Virus-Type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products. Retrovirology 3:80

Comments

Be the first to comment on Linda Ludwig's grant